Market Intel: Bigfoot Biomedical, Beta Bionics Getting Pumped To Introduce Next-Gen Artificial Pancreas
The insulin pump market, which is dominated by four major players, is facing rising competition from smaller, innovative companies. This second part of a two-part series focuses on five emerging companies: Beta Bionics, Bigfoot Biomedical, Diabeloop, EOFlow and Ypsomed.
You may also be interested in...
The US FDA granted 510(k) clearance to Beta Bionics iLet ACE Pump and dosing decision software for treating type 1 diabetes with less diet monitoring.
Exec Chat: Glooko CEO Talks Differentiation, Collaboration And The Future Of Digital Diabetes Solutions
Medtech Insight talked to Russ Johannesson about Glooko’s connected diabetes care strategy, including its recent agreement with John Hopkins HealthCare Solutions and acquisition of Diabnext, a French competitor.
Dexcom’s CEO explained the company’s strategy for continued growth, including marketing opportunities for its G6 and G6 Pro continuous glucose monitors and plans for the next-gen G7 CGM.